MS
Morgan Stanley disclosed a 5.7% stake in AGIO
Morgan Stanley reported owning 5.7% of Agios Pharmaceuticals, Inc. (AGIO) (3,431,830 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G